SEC Form D private-offering filing
Duke Street Bio Ltd
A new SEC Form D private-offering notice from London, a $4,136,978 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biotech developing next-generation cancer therapies targeting DNA damage response and immuno-oncology pathways.
Filed 2026-06-11Filed to raise $4,136,978First money in 2026-05-15Raised so far $4,136,978HQ (as filed) LondonSector Biotech ✓Stage (inferred) SeedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified dukestbio.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.